Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Active transport of L-dopa in the intestine.

× No keyword cloud information.

33 in total

1. The role of the liver in the clearance of l-dope from plasma.

Authors: P T Mearrick; G G Graham; D N Wade
Journal: J Pharmacokinet Biopharm Date: 1975-02

Review 2. Stereoselectivity in clinical pharmacokinetics and drug development.

Authors: D B Campbell
Journal: Eur J Drug Metab Pharmacokinet Date: 1990 Apr-Jun Impact factor: 2.441

3. The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.

Authors: D R Robertson; I Higginson; B S Macklin; A G Renwick; D G Waller; C F George
Journal: Br J Clin Pharmacol Date: 1991-04 Impact factor: 4.335

Review 4. Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors: R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal: Clin Pharmacokinet Date: 1991-03 Impact factor: 6.447

5. Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa.

Authors: D Deleu; G Ebinger; Y Michotte
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

6. Stereoselective disposition of flurbiprofen in normal volunteers.

Authors: M P Knadler; D C Brater; S D Hall
Journal: Br J Clin Pharmacol Date: 1992-04 Impact factor: 4.335

Review 7. Chirality. Clinical pharmacokinetic and pharmacodynamic considerations.

Authors: E J Lee; K M Williams
Journal: Clin Pharmacokinet Date: 1990-05 Impact factor: 6.447

8. Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester.

Authors: F Stocchi; L Barbato; L Bramante; G Nordera; L Vacca; S Ruggieri
Journal: J Neurol Date: 1996-05 Impact factor: 4.849

9. Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.

Authors: Dag Nyholm; Per Odin; Anders Johansson; Krai Chatamra; Charles Locke; Sandeep Dutta; Ahmed A Othman
Journal: AAPS J Date: 2012-12-11 Impact factor: 4.009

10. Methyldopa kinetics before and after ingestion of methyldopa for eight weeks.

Authors: N R Campbell; A Skerjanec; Y Tam; S Robertson; E Burgess
Journal: Eur J Clin Pharmacol Date: 1995 Impact factor: 2.953